Manufacturers Life Insurance Company, The Viracta Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.87 - $5.0 $19,154 - $51,215	-10,243 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$2.23 - $4.76 $22,841 - $48,756	10,243 New	10,243 $48,000
Q1 2022 May 20, 2022	SELL	$2.23 - $4.76 $14,637 - $31,244	-6,564 Reduced 39.06%	10,243 $49,000
Q4 2021 Feb 16, 2022	SELL	$3.37 - $7.91 $15,404 - $36,156	-4,571 Reduced 21.38%	16,807 $61,000
Q3 2021 Nov 12, 2021	SELL	$7.84 - $12.53 $3,896 - $6,227	-497 Reduced 2.27%	21,378 $171,000
Q2 2021 Aug 12, 2021	BUY	$7.55 - $12.95 $165,156 - $283,281	21,875 New	21,875 $248,000

5.63M

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.